Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer.
Yokoo
Koji
K
Watanabe
Hiroshi
H
Hamada
Akinobu
A
Masa
Kengo
K
Saito
Hideyuki
H
Terazaki
Hisayasu
H
Sasaki
Yutaka
Y
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004338:Drug Combinations; D006801:Humans; D000077146:Irinotecan; D008875:Middle Aged; D010094:Oxonic Acid / Q000494:pharmacology*; D005641:Tegafur / Q000494:pharmacology*; D013997:Time Factors
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000077146:Irinotecan; D002166:Camptothecin